Scientists have devised a technique to sort out which heart cells can replicate and which cannot, a critical step toward treatments that may one day help the heart heal itself after injury.
The method, published in the journal Circulation Research, removes a significant roadblock to developing ways to regrow healthy cardiac muscle tissue, a feat not currently possible.
“This new technique solves a longstanding problem that for years has stymied our ability to develop regenerative treatments for the heart,” said Stefan Jovinge, M.D., Ph.D., the study’s senior author and director of the DeVos Cardiovascular Research Program at Van Andel Institute and Spectrum Health. “It’s a major step forward that we aim to translate into improved patient care.”
For decades, scientists have searched for ways to harness the heart’s regenerative potential to fix damage related to heart attack and heart failure, but their attempts have been largely unsuccessful.
Unlike the skin or bones, which readily heal by stitching together wounds or breaks with new, healthy cells, heart muscle cells largely lose their ability to replicate early in life (instead, they progress through the cell cycle but, in most cases, they do not actually divide). This leaves patients and physicians with only a few surgical options to mitigate further damage and just one option to totally repair the problem should the damage be too severe: a heart transplant.
The new method combines two technologies — molecular beacon technology and fluorescence activated cell-sorting — to specifically isolate cells that successfully divide. This will allow scientists to determine the mechanisms underlying heart muscle cells’ regenerative potential, which is critical to the development of regenerative strategies aimed to cure patients with heart injury.
“Now that we can accurately identify these cells, we can start to determine the mechanisms that allow them to divide and develop ways to jump-start this process,” Jovinge said. “This work is an excellent example of how basic research can have a major impact on future clinical care.”
The findings build on previous research by Jovinge’s team that showed, contrary to long-held beliefs, some cells in the heart are indeed capable of replicating. This discovery was hailed as a “notable advance of 2015” by Nature Medicine, one of the world’s top medical research journals.
The Latest on: Regenerative cardiac therapies
via Google News
The Latest on: Regenerative cardiac therapies
- Therapy Insight: Cardiovascular Complications Associated With Muscular Dystrophyon February 21, 2021 at 4:00 pm
These therapies are expected to also improve the cardiac function ...  In normal skeletal muscle, there is a robust regenerative response that leads to the formation of new myofibers, but ...
- Hydrogel injection may change the way the heart muscle heals after a heart attackon February 19, 2021 at 9:43 am
Myocardial infarction or heart disease is a leading cause of death due to the irreversible damage caused to the heart muscle (cardiac tissue ... advanced hydrogels for regenerative medicine.
- Stem Cells Market to Inspire a Growth up to US$ 18,289.9 Million at a 9.1% CAGR by 2027on February 17, 2021 at 11:01 pm
Stem cells are undifferentiated cells which are capable of differentiating into any type of cell that make-up the human body and thus, are capable of producing non-regenerative cells such as neural ...
- Novel Therapy Improves Diabetes Treatmenton February 16, 2021 at 4:23 pm
The research led by Professor Sam El-Osta at Monash University is published in the journal Regenerative Medicine ... The current therapy focuses on replacing the damaged β-cell mass in diabetic ...
- Essent Biologics Announces Derek Mathers as Head of Business Developmenton February 16, 2021 at 10:14 am
© 2021 Insider Inc. and finanzen.net GmbH (Imprint). All rights reserved. Registration on or use of this site constitutes acceptance of our Terms of Service and ...
- Immunomodulation for optimal cardiac regeneration: insights from comparative analyseson February 15, 2021 at 3:06 am
A significant obstacle facing experimental regenerative therapies is the hostile immune response which arises following a myocardial infarction (MI). Upon cardiac damage, ...
- Cell Therapy Market Size Is Estimated to Reach USD 20,217 Million at a 22.36% CAGR By 2023on February 4, 2021 at 11:54 am
The advancement of cellular therapies, the implementation of new technology, and the growing acceptance of regenerative medicine ... incidences of cancer and cardiac illness can augment the ...
- A blueprint for translational regenerative medicineon February 2, 2021 at 4:00 pm
Regenerative medicine therapies can involve the administration of cells ... such as the injection of skeletal myoblasts for cardiac regeneration (3). A third criterion is whether to use committed cell ...
- BioCardia Update on Cell Therapy Product Development and 2021 Milestoneson February 2, 2021 at 5:37 am
The Helix system, used in all three of our cardiac programs ... is developing regenerative biologic therapies to treat cardiovascular and respiratory disease. CardiAMP autologous and Neurokinin ...
via Bing News